Data Sheet 1_Combined neutrophil-to-lymphocyte ratio and nomogram for predicting progressi

A retrospective cohort of 148 patients with metastatic or recurrent cervical cancer treated with immune checkpoint inhibitors (ICIs). The data was used to evaluate the predictive importance of the combined neutrophil-to-lymphocyte ratio (Combined.NLR) and to develop a prognostic nomogram. The dataset was authored by Zhen Xu and last updated in April 2026.

Use Cases

• Predicting progression-free survival (PFS) based on the Combined.NLR biomarker.
• Building prognostic nomograms incorporating histological type and PD-L1 expression.
• Analyzing the impact of multi-organ metastasis and prior treatment lines on immunotherapy response.

Strengths

• Includes data for 148 patients, a specific cohort size.
• Features a developed nomogram with a reported concordance index of 0.70.
• Published under a CC-BY-4.0 license, allowing for reuse and modification.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data is from a single-center retrospective study, which may limit generalizability.

Provenance

Source

figshare, authored by Zhen Xu.

Collection Method

Retrospective cohort analysis performed at a single center.

Time Range

null

Freshness

Last updated 2026-04-14 05:10:31; freshness should be verified.

Geography

null